Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes by unknown
Klingberg et al. Arthritis Research & Therapy 2013, 15:R179
http://arthritis-research.com/content/15/6/R179RESEARCH ARTICLE Open AccessBone microarchitecture in ankylosing spondylitis
and the association with bone mineral density,
fractures, and syndesmophytes
Eva Klingberg1*, Mattias Lorentzon2, Jan Göthlin3, Dan Mellström2, Mats Geijer4, Claes Ohlsson2,
Elizabeth J Atkinson5, Sundeep Khosla6, Hans Carlsten1 and Helena Forsblad-d’Elia1Abstract
Introduction: Osteoporosis of the axial skeleton is a known complication of ankylosing spondylitis (AS), but bone
loss affecting the peripheral skeleton is less studied. This study on volumetric bone mineral density (vBMD) and
bone microarchitecture in AS was conducted to compare peripheral vBMD in AS patients with that in healthy
controls, to study vBMD in axial compared with peripheral bone, and to explore the relation between vertebral
fractures, spinal osteoproliferation, and peripheral bone microarchitecture and density.
Methods: High-resolution peripheral quantitative computed tomography (HRpQCT) of ultradistal radius and tibia
and QCT and dual-energy x-ray absorptiometry (DXA) of lumbar spine were performed in 69 male AS patients
(NY criteria). Spinal radiographs were assessed for vertebral fractures and syndesmophyte formation (mSASSS). The
HRpQCT measurements were compared with the measurements of healthy controls.
Results: The AS patients had lower cortical vBMD in radius (P = 0.004) and lower trabecular vBMD in tibia
(P = 0.033), than did the controls. Strong correlations were found between trabecular vBMD in lumbar spine, radius
(rS = 0.762; P < 0.001), and tibia (rS = 0.712; P < 0.001).
When compared with age-matched AS controls, patients with vertebral fractures had lower lumbar cortical vBMD
(-22%; P = 0.019), lower cortical cross-sectional area in radius (-28.3%; P = 0.001) and tibia (-24.0%; P = 0.013), and
thinner cortical bone in radius (-28.3%; P = 0.001) and tibia (-26.9%; P = 0.016).
mSASSS correlated negatively with trabecular vBMD in lumbar spine (rS = -0.620; P < 0.001), radius (rS = -0.400;
p = 0.001) and tibia (rS = -0.475; p < 0.001) and also with trabecular thickness in radius (rS = -0.528; P < 0.001) and
tibia (rS = -0.488; P < 0.001).
Adjusted for age, syndesmophytes were significantly associated with decreasing trabecular vBMD, but increasing
cortical vBMD in lumbar spine, but not with increasing cortical thickness or density in peripheral bone. Estimated
lumbar vBMD by DXA correlated with trabecular vBMD measured by QCT (rS = 0.636; P < 0.001).
Conclusions: Lumbar osteoporosis, syndesmophytes, and vertebral fractures were associated with both lower
vBMD and deteriorated microarchitecture in peripheral bone. The results indicate that trabecular bone loss is
general, whereas osteoproliferation is local in AS.* Correspondence: Eva.Klingberg@vgregion.se
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Ankylosing spondylitis (AS) is a chronic inflammatory
rheumatic disease predominantly affecting the sacroiliac
joints and the vertebral column. The disease often leads to
the formation of spinal syndesmophytes and impaired
back mobility, especially in male patients. Patients with
AS have, in comparison with the general population, an
increased risk of developing osteoporosis and fractures,
especially vertebral fractures, but also other fractures, in-
cluding hip fractures [1-6]. Male sex, old age, long disease
duration, elevated inflammatory parameters, advanced
chronic AS-related changes in the spine, and poor back
mobility have been identified as risk factors for osteo-
porosis and vertebral fractures [7-13]. The mechanisms
behind inflammation, new-bone formation and osteopo-
rosis in AS are incompletely understood.
Measurements of lumbar area bone mineral density
(aBMD) with dual-energy x-ray absorptiometry (DXA) in
the anteroposterior (AP) projection are unreliable in AS,
because of the spinal osteoproliferation [13-15]. Further-
more, prospective studies of the general population have
shown that aBMD identifies only 20% of men who will later
sustain a fracture [16,17]. Bone strength depends partly on
bone mineral content, but also on the bone geometry and
microarchitecture of cortical and trabecular bone [18-20].
Quantitative computed tomography (QCT) has the advan-
tage of assessing volumetric BMD (vBMD) in the lumbar
spine in cortical and trabecular bone separately, without
including areas of hyperostosis in the measurements [15].
The development of high-resolution peripheral quanti-
tative computed tomography (HRpQCT) has enabled us
to study bone in great detail, without the need of biopsies.
Although several studies exist on osteoporosis in AS, the
knowledge of the bone microarchitecture in the disease is
still sparse. The evolving technique of HRpQCT offers
new possibilities to study further the intricate association
between new bone formation and osteoporosis in AS and
also to follow up the effects of treatment for osteoporosis
and inflammation on bone tissue. This is, to our best
knowledge, the first study on bone microarchitecture in
AS with HRpQCT.
The aims of the present study were to (a) study peri-
pheral vBMD in AS patients in comparison with healthy
controls, (b) compare vBMD of trabecular and cortical
bone in the axial and peripheral skeleton, (c) explore the
relation between bone microarchitecture and presence of
vertebral fractures and syndesmophytes, and (d) compare




In total, 69 male AS patients who had been included in
a larger study on osteoporosis in the west of Swedenwere randomized in an age-adjusted algorithm also to
take part in the current study on HRpQCT and QCT.
All AS patients registered at the Rheumatology Clinic at
Sahlgrenska University Hospital in Gothenburg, and the
Rheumatology Clinics at Borås and Alingsås county hospi-
tals had been invited to take part in the initial study. The
inclusion of the 204 patients in the initial study has been
described in detail [13]. In summary, all included patients
met the modified New York criteria for AS [21] .Exclusion
criteria were psoriasis, inflammatory bowel disease, de-
mentia, and difficulties in understanding Swedish. Written
informed consent was obtained from all patients. The
study was approved by the Regional Ethical Review Board
in Gothenburg and carried out in accordance with the
Helsinki declaration.
Healthy controls
The HRpQCT results regarding trabecular and cortical
vBMD of the AS patients were compared with the results
of a control group consisting of 68 healthy individuals
measured with the same type of XtremeCT at the Mayo
Clinic in Rochester, Olmsted County, Minnesota, USA.
The healthy controls were matched for age, height, weight,
and race. No control could be found for the youngest pa-
tient, who thus was excluded from these calculations.
High-resolution peripheral quantitative computed
tomography
Bone microarchitecture was examined by using an HRp-
QCT device (XtremeCT; Scanco Medical AG, Brüttisellen,
Switzerland) in the nondominant ultradistal radius and
tibia. The patient’s forearm and leg were immobilized in
especially designed carbon-fiber shells (Scanco Medical)
to prevent movement during the procedure.
The quality of the measurements was assessed by using
a 5-point scale recommended by the manufacturer (1, ex-
cellent; 2, good; 3, acceptable; 4, unacceptable; 5, poor).
Only examinations with quality grades 1 through 3 were
included in the study, whereas grades 4and 5 were
excluded, mostly because of motion artefacts. Totally 12
examinations of the radius had to be repeated because of
to movement artifacts. Seven patients had measurements
of the ultradistal radius with unacceptable quality and
were thus excluded, whereas all tibia measurements were
included.
The volumes of interest (VOIs), 9-mm sections of radius
and tibia, were examined in 110 parallel slices (voxel size,
82 μm), generating a 3D representation of the bone. The
first CT slices started 9.5 mm and 22.5 mm proximal to a
reference line manually placed at the center of the end
plate of the distal radius and tibia, respectively, and con-
tinued proximally.
The VOIs were automatically separated into a trabecular
and a cortical region. With previously described data-
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trabecular and cortical bone were obtained: trabecular
volumetric BMD (DTrab; mg/cm3), trabecular bone vo-
lume/total volume (BV/TV; %), trabecular number (TbN;
per mm), trabecular thickness (TbTh; μm), trabecular
separation or spacing (TbSp; μm), cortical volumetric
BMD (DCort; mg/cm3), cortical bone cross-sectional
area (CortCSA; mm2), cortical periosteal circumference
(CortPm; mm), and cortical thickness (CortTh; μm)
[22-26]. DTrab, DCort, TbN, CortCSA, and CortPm were
measured directly, and the other parameters were derived.
The coefficients of variation (CVs) for repeated mea-
surements by using the XtremeCT apparatus in Gothen-
burg ranged between 0.3% and 3.9% of the radius and
from 0.1% to 1.6% of the tibia. The same device, soft-
ware, and operator were used throughout the study.
The software Autocontouring and Eval Crtx 6× soft-
ware, provided by Scanco Incorporated in the manufac-
turer’s Image Processing Language (IPL) software (μCT
Evaluation Program v6; Scanco Medical AG, Brüttisellen,
Switzerland) was used to assess cortical bone micro-
structure of the ultradistal radius and tibia. The cortical
compartment in the VOI was detected automatically by
identifying the endosteal and periosteal contours. All
void voxels within the cortical compartment were identi-
fied, and the images were digitally superimposed, gene-
rating a refined cortical compartment region in the VOI.
The Haversian canals were distinguished from artefacts
because of surface roughness, transcortical foramens, or
erosions. With this method, cortical porosity (CtPo; %)
and mean cortical pore diameter (CtPoDiam; μm) were
obtained [22,23,25]. The CVs for porosity were 15.9% at
the radius and 5.5% at the tibia, and the CVs for mean
cortical pore diameter were 6.0% at the radius and 3.9%
at the tibia.
The healthy control group was assessed with the same
type of XtremeCT at the Mayo Clinic in Rochester. A
scan phantom for the vBMD measurements was sent
from Gothenburg to Rochester for cross-calibration of
the XtremeCT devices. Linear regression between the
phantom measurements in Gothenburg and Rochester
generated a formula
X  0:995ð Þ þ 1:148ð Þ
by which the values from Rochester were subsequently
adjusted. The phantom was not designed for cross-
calibration of microarchitectural parameters; hence those
parameters could not be compared in the patients and
controls.
Quantitative computed tomography
Lumbar volumetric BMD was measured in the vertebrae
L1 through L4 by using a QCT scanner (SiemensSomatom Sensation 16 with application Syngo Osteo
CT; Siemens AG, Munich, Germany). Volumetric BMD
(vBMD; mg/cm3) was assessed separately in the cortical
and the trabecular bone in 10-mm-thick slices of each
vertebra. All patients were scanned together with a
water- and bone-equivalent calibration phantom placed
below the patients along with an interpositioned gel pad
to prevent artefacts and air gaps. The BMD results of
the patients were compared with the reference popu-
lation database of the CT scanner software, including
135 male and 139 female European subjects, 20 through
80 years of age.
Dual-energy x-ray absorptiometry
BMD was measured with DXA (Hologic Discovery A;
Hologic Inc., Bedford, MA, USA) in the nondominant
forearm (total radius, radius 1/3) and hip (total hip, femoral
neck) and in the lumbar spine (in AP L1 through L4 and
lateral L2 through L4 projection) with estimation of lum-
bar vBMD.
Radiography
Lateral radiographs of the spinal column were taken to
study the presence of vertebral fractures in the thoracic and
lumbar spine by using the Genant score, which scores ver-
tebrae on visual inspection as normal, mildly, moderately,
or severely deformed (grades 0 to 3) [27]. All vertebral frac-
tures (Genant score, 1 through 3) were included in the
calculations. The presence of chronic AS changes in the
cervical and lumbar spine was assessed by using the modi-
fied Stoke Ankylosing Spondylitis Spine Score (mSASSS)
[28] .The score grades the anterior vertebral corners with 0
through 3 points each (0, normal; 1, erosion, sclerosis, or
squaring; 2, syndesmophyte; or 3, bridging syndesmophyte).
The scoring scale ranges from 0 to 72.
Statistical analysis
Statistical analyses were performed by using PASW Statis-
tics 18.0 (SPSS Inc., IBM, Chicago, IL, USA). Descriptive
statistics are presented as median and range and/or mean
and standard deviation (SD). The Mann–Whitney U test,
t test, or the χ2 test was used to compare variables as
appropriate. Correlations were calculated by using the
Spearman correlation (rs). Logistic regressions with a for-
ward conditional method were run with the presence of a
syndesmophyte (yes/no) and vertebral fracture (yes/no) as
the binary outcome. All tests were two-tailed, and P < 0.05
was considered statistically significant.
Results
Patients
In total, 69 male AS patients were included in the study.
The characteristics of the patients are presented in
Table 1.
Table 1 Characteristics of 69 male patients with
ankylosing spondylitis in western Sweden
n (%) Median (range) Mean ± SD
Age, years 48 (17, 78) 49 ± 15
Years since symptom onset 20 (2, 55) 23 ± 14
Present or past iritis 37 (54)
Present or past synovitis 37 (54)
Patients with a vertebral fracture 8 (12)
mSASSS 8 (0, 72) 19 ± 21
BASMI, score 3.0 (1.0, 7.2) 3.2 ± 1.6
BASDAI, score 2.7 (0.2, 7.9) 3.1 ± 2.0
ASDAS, score 2.1 (1.0, 4.4) 2.3 ± 0.9
BAS-G 2.2 (0, 9.8) 3.0 ± 2.7
BASFI, score 2.0 (0, 8.7) 2.6 ± 2.2
ESR, mm/h 10 (2, 73) 14 ± 12
CRP, mg/L 5 (3, 71) 9 ± 12
HLA-B27 positive 65 (94)
Patients taking NSAID 52 (75)
Patients taking glucocorticoid 1 (1)
Patients taking DMARD 21 (30)
Methotrexate 13 (19)
Sulfasalazine 5 (7)
TNF inhibitors 15 (22)
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, BAS Functional
Index; BASG1, BAS Patient Global score; BASMI, BAS Metrology Index; ESR,
erythrocyte sedimentation rate; CRP, C-reactive protein; NSAID, nonsteroidal
antiinflammatory drug; DMARD, disease-modifying antirheumatic drug;
TNF, tumor necrosis factor; mSASSS, modified Stoke Ankylosing Spondylitis
Spine Score.
Table 2 Comparison of the demographics and HRpQCT








Demographics Male % 100 100
Age (years) 49 ± 14 49 ± 14 0.993
BMI kg/m2 26.6 ± 4.4 27.8 ± 4.6 0.117
Height cm 177 ± 7 179 ± 7 0.358
Weight kg 84 ± 14 89 ± 16 0.052
HRpQCT radius DTrab mg/cm3 181 ± 39 187 ± 39 0.460
DCort mg/cm3 850 ± 55 874 ± 42 0.007
HRpQCT tibia DTrab mg/cm3 187 ± 35 201 ± 41 0.033
DCort mg/cm3 844 ± 53 845 ± 44 0.944
The youngest AS patient was excluded from this analysis because of lack of a
healthy control. Calculations on the tibia were made on 68 patients and controls
and on radius of 61 patients and controls. The HRpQCT measurements of the
radius from seven AS patients had to be excluded towing to motion artefacts.
BMI, body mass index; DCort, vBMD of cortical peripheral bone; DTrab, vBMD of
trabecular peripheral bone; HRpQCT, high-resolution peripheral quantitative
computed tomography.
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compared with the healthy controls
The AS patients had, in comparison with the controls, sig-
nificantly lower vBMD in cortical bone of the ultradistal
radius (P = 0.007) and in trabecular bone of the ultradistal
tibia (P = 0.033) (Table 2). The AS patients also had lower
weight and body mass index (BMI) than the controls, but
the differences did not reach a level of significance.
Weight and BMI were, however, not correlated with tra-
becular or cortical vBMD in the ultradistal radius or tibia.
(Correlation coefficients ranged from -0.082 to 0.100, and
P values ranged from 0.245 to 0.853).
Correlation between spinal vBMD measured with QCT
and peripheral bone microarchitecture measured with
HRpQCT
Strong correlations were found between trabecular
vBMD in the lumbar spine, ultradistal radius (rS = 0.762;
P < 0.001) and tibia (rS = 0.712; P < 0.001), but the cor-
tical vBMD of the spine and peripheral skeleton were
not significantly correlated (Figure 1 and Table 3). Low-
lumbar trabecular vBMD was also significantly correlatedwith parameters indicating poor bone microarchitecture,
such as thinner trabeculae, lower trabecular number, thin-
ner cortex, lower cortical vBMD, and increased cortical
porosity (Figure 2 and Table 3). The results thus indicated
a link between trabecular bone loss in the axial and peri-
pheral skeleton in AS.
Trabecular and cortical vBMD were significantly cor-
related in the ultradistal radius (rS = 0.466; P < 0.001)
and tibia (rS = 0.308; P < 0.010), but the correlation did
not reach the level of significance (rS = 0.230; P = 0.061)
in the lumbar spine.
Vertebral fractures in relation to bone mineral density
and peripheral bone microarchitecture
Vertebral fractures were diagnosed in eight (12%) pa-
tients, the youngest patient being 31, and the oldest,
71 years old. Twelve vertebral fractures with Genant
score grade 1 and two with grade 2 were diagnosed in
the study group. Age, disease duration, and mSASSS
score were not significantly different between patients
with or without a vertebral fracture.
Each patient with a vertebral fracture was compared
with two age-matched AS controls from the same cohort
(Table 4). The patients with a vertebral fracture had sig-
nificantly lower cortical lumbar vBMD measured with
QCT compared with the age-matched nonfractured pa-
tients. The following DXA parameters were also signifi-
cantly lower in the patients with a vertebral fracture: AP
and lateral lumbar BMD, lumbar vBMD, and BMD of
the hip (femoral neck and total hip).
No significant difference in BMD was found in the
forearm measured by DXA between the groups. When
Figure 1 The correlations between trabecular volumetric BMD in the lumbar spine, ultradistal radius, and tibia.
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fracture, however, displayed significantly lower trabecu-
lar and cortical vBMD in the ultradistal radius and, in
addition, lower trabecular thickness, cortical thickness,
and cross-sectional area in both the ultradistal radius
and tibia, thus indicating deteriorated peripheral bone
microarchitecture in the fractured patients in compa-
rison with the age-matched AS controls. The greatest
differences between the fractured and nonfractured
patients were found in cortical thickness and cortical
cross-sectional area (Table 4).
Multiple logistic regression was run with vertebral
fracture as binary outcome. In the first model, in which
age, mSASSS, and trabecular and cortical lumbar vBMD
were entered as covariates, decreasing cortical lumbar
vBMD (B = -0.023; P = 0.015; OR, 0.977; 95% CI, 0.959
to 0.996), and increasing mSASSS (B = 0.042; P = 0.049;
OR, 1.04; 95% CI, 1.0003 to 1.087) were independently
associated with the presence of a vertebral fracture.
In the second model, in which the HRpQCT parame-
ters were directly measured and not derived (DTrab,
DCort, TbN, CortCSA, and CortPm) were additionally
entered, only decreasing cortical cross-sectional area of
the tibia (B = -0.063; P = 0.008; OR, 0.939; 95% CI, 0.897
to 0.984) remained significantly associated with the pres-
ence of a vertebral fracture.
Syndesmophyte formation in relation to spinal vBMD
measured with QCT and peripheral bone
microarchitecture
Increasing mSASSS correlated significantly with increa-
sing age (rS = 0.546; P < 0.001) and decreasing trabecular
vBMD in the lumbar spine (rS = -0.620; P < 0.001). In
addition, mSASSS correlated with increasing cortical po-
rosity and decreasing trabecular thickness and vBMD of
trabecular and cortical bone in the periphery (Table 3).In 39 patients, radiographs of the cervical and lumbar
spines revealed at least one syndesmophyte or bridging
syndesmophyte, whereas nine patients had a disease
restricted to the sacroiliac joints (mSASSS = 0), and 21
patients had only the presence of erosions, sclerosis, or
squaring at the vertebral corners.
The patients with at least one syndesmophyte had,
in comparison with patients without syndesmophytes,
significantly older age (54 ± 12 versus 42 ± 15 years;
P = 0.001), thinner trabeculae in the ultradistal radius
(0.071 ± 0.016 versus 0.085 ± 0.014, P < 0.001) and tibia
(0.072 ± 0.013 versus 0.081 ± 0.008; P = 0.001) and lower
trabecular vBMD in the lumbar spine (100 ± 36 versus
146 ± 33; P < 0.001), ultradistal radius (171 ± 42 versus
196 ± 29; P = 0.013) and tibia (175 ± 37 versus 205 ± 27;
P < 0.001).
In a multiple logistic regression model with the presence
of at least one syndesmophyte as the binary outcome and
adjusting for age, decreasing lumbar trabecular vBMD
(B = -0.058; P < 0.001; OR = 0.943; 95% CI, 0.917 to 0.970),
but increasing lumbar cortical vBMD (B = 0.019; P =
0.016; OR, 1.019; 95% CI, 1.004 to 1.035) remained in-
dependently associated with syndesmophyte formation.
None of the HRpQCT parameters was significantly asso-
ciated with presence of syndesmophytes after adjusting for
age in logistic regression. Covariates in the regression
model were age, trabecular and cortical lumbar vBMD,
and the HRpQCT parameters, which were directly mea-
sured and not derived (DTrab, DCort, TbN, CortCSA,
and CortPm).
Comparisons of BMD measured with QCT and with DXA
in AP and lateral projections in the lumbar spine
QCT revealed significantly more cases with T score ≤2.5
SD (n = 26; 38%) and T score ≤1.0 SD (n = 21; 30%) than
AP DXA, showing considerably less osteoporosis (n = 4;
Table 3 The correlation (Spearman rho) between the HRpQCT parameters, age, lumbar QCT, and mSASSS in the AS patients
HRpQCT radius DTrab (mg/cm3) BV/TV (%) Tbth (μm) TbN (per mm) TbSp (μm) DCort (mg/cm3) CortTh (μm) CtPo (%) CtPoDiam (μm)
Age -0.471 -0.473 -0.507 -0.040 0.166 -0.337 -0.228 0.540 0.055
P < 0.001 P < 0.001 P < 0.001 P = 0.755 P = 0.198 P = 0.007 P = 0.075 P < 0.001 P = 0.663
Lumb QCT 0.762 0.763 0.737 0.106 -0.304 0.425 0.420 -0.480 - 0.136
Trab vBMD P < 0.001 P < 0.001 P < 0.001 P = 421 P = 0.018 P = 0.001 P = 0.001 P < 0.001 P = 0.290
Lumb QCT 0.296 0.298 0.152 0.296 - 0.341 0.123 0.152 0.032 0.006
Cort vBMD P = 0.021 P = 0.021 P = 0.246 P = 0.022 P = 0.008 P = 0.348 P = 247 P = 0.805 P = 0.961
Msasss - 0.400 - 0.400 - 0.528 0.077 0.039 - 0.192 - 0.196 0.352 0.022
P = 0.001 P = 0.001 P < 0.001 P = 0.552 P = 0.761 P = 0.135 P = 0.128 P = 0.004 P = 0.861
HRpQCT tibia DTrab BV/TV Tbth TbN TbSp DCort CortTh CtPo CtPoDiam
(mg/cm3) (%) (μm) (mm-1) (μm) (mg/cm3) (μm) (%) (μm)
Age - 0.470 - 0.471 - 0.479 - 0.185 0.246 - 0.436 - 0.202 0.521 0.210
P < 0.001 P < 0.001 P < 0.001 P = 0.127 P = 0.042 P < 0.001 P = 0.096 P < 0.001 0.084
Lumb QCT 0.712 0.714 0.523 0.363 - 0.443 0.454 0.403 - 0.496 - 0.437
Trab vBMD P < 0.001 P < 0.001 P < 0.001 P = 0.003 P < 0.001 P < 0.001 P = 0.001 P < 0.001 P < 0.001
Lumb QCT 0.336 0.336 0.027 0.356 - 0.367 0.135 0.151 - 0.102 - 0.162
Cort vBMD P = 0.005 P = 0.005 P = 0.827 P = 0.003 P = 0.002 P = 0.276 P = 0.223 P = 0.410 P = 0.191
mSASSS - 0.475 - 0.475 - 0.488 - 0.105 0.176 - 0.315 -0.161 0.363 0.169
P < 0.001 P < 0.001 P < 0.001 P = 0.392 P = 0.148 P = 0.008 P = 0.186 P = 0.002 P = 0.169
BV/TV, trabecular bone volume fraction; Cort, cortical; DCort, vBMD of cortical peripheral bone; DTrab, vBMD of trabecular peripheral bone; CortTh, cortical thickness peripheral bone; CtPo, cortical porosity; CtPoDiam,
mean cortical pore diameter; HRpQCT, high-resolution peripheral quantitative computed tomography; Lumb, lumbar; TbN, trabecular number peripheral bone; TbSp, trabecular separation peripheral bone; Tbth,trabecular















Figure 2 HRpQCT images of ultradistal radius and tibia. (A) 3D representation of ultradistal tibia. AS patient with normal BMD. (B) 3D
representation of ultradistal radius. AS patient with osteoporosis. (C) 2D representation of ultradistal tibia. AS patient with normal BMD. (D) 2D
representation of ultradistal tibia. AS patients with lumbar osteoporosis. Note the low trabecular number and thickness, high trabecular
separation, and low cortical thickness.
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rence database values were available for lateral lumbar
DXA and DXA vBMD lumbar spine.
The patients with at least one syndesmophyte had sig-
nificantly reduced Z scores of lumbar vBMD measured
with QCT (mean Z score, -0.624 ± 1.186; P = 0.003),
whereas AP lumbar DXA showed no significant reduc-
tion of the Z scores of lumbar BMD in patients with or
without syndesmophytes, thus indicating that the QCT
results were less affected by syndesmophyte formation
than was the AP lumbar DXA.
Correlation analyses between lumbar QCT and lumbar
DXA demonstrated that QCT trabecular vBMD had
the strongest correlation with DXA vBMD (rS = 0.636;
P < 0.001) followed by lateral BMD (rS = 0.537; P < 0.001)
and AP BMD (rS = 0.380; P = 0.002). QCT cortical vBMD
correlated with DXA in the following way: lateral BMD
(rS = 0.595; P < 0.001), AP BMD (rS = 0.541; P = 0.002)
and vBMD (rS = 0.431; P < 0.001).
Discussion
In the present study, we used new imaging techniques,
peripheral HRpQCT and lumbar QCT, to investigate the
relation between osteoporosis, osteoproliferation, andfractures in the spine and morphology and bone density
in the peripheral skeleton.
When measured with HRpQCT, the patients with AS
had lower vBMD in the peripheral skeleton than did
healthy controls; the AS patients had significantly lower
vBMD in the cortical bone of the radius and the trabecu-
lar bone of the tibia. The controls were slightly heavier
than the AS patients, but it seems unlikely that this would
explain the difference, because vBMD in ultradistal radius
and tibia were not correlated with weight or BMI.
The HRpQCT measurements of the radius from seven
patients had to be excluded for motion artefacts. Abso-
lute immobilization of the limb is required during the
procedure, but in a few patients, an optimal positioning
was difficult to obtain, because of stiffness of the spine
or joints.
It was previously argued that osteoporosis in AS affects
mainly the axial skeleton [12,29,30]. The current study
indicates, nevertheless, that axial and peripheral trabecular
bone loss are connected in AS. Spinal and peripheral
trabecular vBMD were strongly correlated. Decreasing
lumbar vBMD measured with QCT was, in addition, asso-
ciated with deteriorated peripheral bone microarchi-
tecture, such as thinner trabeculae, higher trabecular
Table 4 BMD and microarchitectural parameters in AS patients with a vertebral fracture compared with age-matched
AS patients without a vertebral fracture
Patients without a vertebral
fracture (mean ± SD)
Patients with a vertebral
fracture (mean ± SD)
Difference% P value
n = 16 n = 8
Age (years) 55.9 ± 12.4 55.6 ± 12.8 −0.01 0.955
QCT lumbar spine Trab vBMD (mg/cm3) 117.17 ± 34.35 92.09 ± 40.94 −21.4 0.128
Cort vBMD (mg/cm3) 366.11 ± 81.62 285.45 ± 52.77 −22.0 0.019
DXA BMD AP lumbar (g/cm2) 1.10 ± 0.11 0.98 ± 0.13 −10.9 0.018
Lat lumbar (g/cm2) 0.80 ± 0.11 0.68 ± 0.10 −15.0 0.021
Lumb vBMD (g/cm3) 0.20 ± 0.03 0.17 ± 0.03 −15.0 0.048
Femoral neck (g/cm2) 0.80 ± 0.11 0.66 ± 0.12 −17.5 0.009
Total hip (g/cm2) 1.00 ± 0.10 0.83 ± 0.13 −17.0 0.002
Radius 1/3 (g/cm2) 0.79 ± 0.05 0.78 ± 0.08 −1.3 0.672
Total radius (g/cm2) 0.66 ± 0.05 0.62 ± 0.07 −6.1 0.188
HRpQCT DTrab (mg/cm3) 195.42 ± 40.31 147.20 ± 27.10 −24.7 0.010
Radius
BV/TV (%) 16.3 ± 3.4 12.3 ± 2.3 −25.0 0.010
Tbth (μm) 83.1 ± 19.9 65.1 ± 7.9 −12.5 0.034
TbN (per mm) 1.98 ± 0.26 1.88 ± 0.23 −5.1 0.388
TbSp (μm) 430.0 ± 66.1 473.1 ± 64.7 +9.3 0.169
DCort (mg/cm3) 862.81 ± 38.45 810.70 ± 68.01 −6.0 0.032
CortTh (μm) 901 ± 163 637 ± 181 −28.9 0.003
CortCSA (mm2) 76.81 ± 11.63 55.11 ± 14.17 −28.3 0.001
CtPo (%) 2.65 ± 0.97 2.39 ± 1.07 −9.8 0.548
CtPoDiam (μm) 172 ± 18 165 ± 15 −4.1 0.548
HRpQCT DTrab (mg/cm3) 189.52 ± 25.76 155.59 ± 39.46 −17.9 0.052
Tibia
BV/TV (%) 15.8 ± 2.1 13.0 ± 3.3 −18.8 0.050
Tbth (μm) 78.6 ± 9.4 68.4 ± 9.4 −12.5 0.020
TbN (per mm) 2.01 ± 0.18 1.88 ± 0.26 −6.4 0.149
TbSp (μm) 421.9 ± 44.8 474.6 ± 89.1 +14.3 0.150
DCort (mg/cm3) 848.24 ± 51.18 810.19 ± 83.08 −4.5 0.263
CortTh (μm) 1,303 ± 297 946 ± 352 −26.9 0.016
CortCSA (mm2) 151.94 ± 26.71 115.50 ± 38.91 −24.0 0.013
Ct Po (%) 7.27 ± 2.94 7.54 ± 3.27 +3.7 0.881
CtPoDiam (μm) 189 ± 16 194 ± 17 +2.6 0.417
Difference (%), mean of fractured – mean of nonfractured⁄mean of nonfractured; BMD, bone mineral density; BV/TV, trabecular bone volume fraction; Cort, cortical;
DCort, vBMD of cortical peripheral bone; DTrab, vBMD of trabecular peripheral bone; DXA, dual-energy x-ray absorptiometry; CortCSA, cortical cross-sectional area
peripheral bone; CortTh,cortical thickness peripheral bone, CtPo = cortical porosity; CtPoDiam, mean cortical pore diameter; HRpQCT, high-resolution peripheral
quantitative computed tomography; TbN, trabecular number peripheral bone; TbSp, trabecular separation peripheral bone; Tbth, trabecular thickness peripheral bone;
Trab, trabecular; vBMD, volumetric BMD; QCT, quantitative computed tomography.
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explain the increased frequency of hip and peripheral
fractures observed in an earlier study on Swedish AS
patients [5].
A plausible reason for the coupling of trabecular bone
loss in the axial and peripheral skeleton is that general
inflammation in AS with systemic elevation of cytokines,such as TNF-α, IL-1, and IL-6, affects osteoclasts and
osteoblasts in all bone tissue. Trabecular bone loss in
the vertebral bodies may, in addition, be enhanced by
local inflammation and alterations of loading due to syn-
desmophytes and ankylosis.
In 1997, a study on 14 men with AS showed that can-
cellous bone volume from iliac crest biopsies correlated
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not with DXA. The trabecular thickness in the biopsies of
the AS patients was found to be lower than the reference
values reported in the literature [31]. In contrast, another
study reported no correlation between vBMD measured
in the forearm with peripheral QCT (pQCT) and QCT
values of the lumbar spine, and pQCT revealed only a few
cases of osteopenia and osteoporosis. However, the pa-
tients were younger than in the present study (mean,
40 versus 49 years), and both sexes were included [7].
HRpQCT and pQCT assess different aspects of bone
quality, which may also explain the discrepancy between
the studies; HRpQCT measures predominantly trabecular
bone in greater detail and in a more distal part of the
radius and tibia, whereas pQCT gives a better evaluation
of cortical bone.
Trabecular number was not associated with lumbar
vBMD or age in the present study. Similarly, studies on
age-related changes in the general population have shown
decreased trabecular thickness, but preserved trabecular
number in men, in contrast to loss of trabecular number
and increased trabecular separation in women [32,33].
The current study also shows that AS patients with ver-
tebral fractures have worse bone microarchitecture and
lower vBMD in both the axial and peripheral skeleton
than do age-matched AS controls. In this aspect, the situ-
ation in AS seems comparable to that in postmenopausal
women and men aged older than 50 years, where vertebral
fractures also have been shown to be associated with poor
peripheral bone microarchitecture [34-36]. We identified
cortical thinning and low cross-sectional area in the
peripheral skeleton as factors strongly associated with ver-
tebral fractures. Interestingly, another study on 920 men
from the general population aged older than 50 also indi-
cated that low cortical thickness and low cortical density
in both the ultradistal radius and tibia were associated
with vertebral fractures [34].
We found that the presence of syndesmophytes was
associated with lower trabecular vBMD but increasing
cortical vBMD in the lumbar spine. The increasing cor-
tical vBMD was presumably reflecting pathologic new-
bone formation in the cortex of the vertebral bodies.
Our findings are supported by an earlier study also
reporting decreasing trabecular but increasing cortical
vBMD in the lumbar spine measured with QCT in AS
patients in advancing stages of ankylosis [37]. The
pathologic new-bone formation in the spine was, how-
ever, not coupled with any signs of hyperostosis in the
peripheral microarchitecture. In contrast, it was asso-
ciated with lower peripheral trabecular density and thin-
ner trabeculae. The findings support the concept of
osteoproliferation as being a local anabolic bone re-
sponse to inflammation, mechanical stress, or micro-
damage, but not a systemic process in AS.In the present study, lateral lumbar BMD and estimated
vBMD by DXA correlated well with QCT measures of
both cortical and trabecular BMD. QCT was more sensi-
tive than AP DXA in revealing reduced BMD in the lum-
bar spine. We recently published data showing that lateral
DXA scanning with estimation of vBMD in comparison
with AP DXA is more sensitive in detecting reduced
BMD, less affected by the pathologic new-bone formation
in the spine, and better associated with vertebral fractures
[13]. QCT has hitherto been considered to be the pre-
ferred method for measuring lumbar BMD in AS, but
radiation doses and availability are, however, problems of
QCT. We propose that lateral lumbar DXA with estima-
tion of vBMD may be a valuable alternative for the assess-
ment of lumbar BMD in AS.
The lack of a Swedish control group for the HRpQCT
measurements is a limitation of the study. The healthy
controls were, however, matched for age, height, weight,
and BMI, and Olmsted county in Minnesota has a high
proportion of inhabitants of Scandinavian descent. Other
limitations are the relatively small reference population
for lumbar QCT and the absence of a reference-popula-
tion database for men regarding lateral lumbar DXA.
Conclusions
The HRpQCT measurements revealed lower vBMD in
the ultradistal radius and tibia in the AS patients com-
pared with the healthy controls. Low-lumbar vBMD, ver-
tebral fractures, and chronic AS-related changes in the
spine were associated with lower vBMD and worse bone
microarchitecture in the peripheral skeleton. The results
indicate that osteoporosis in AS is a general process affec-
ting both the central and the peripheral skeleton, whereas
pathologic new-bone formation is localized.
Abbreviations
AP: Anteroposterior; AS: Ankylosing spondylitis; ASDAS: Ankylosing
spondylitis disease activity acore; BASDAI: Bath ankylosing spondylitis disease
activity score; BASFI: Bath ankylosing spondylitis functional index; BAS-G: Bath
ankylosing spondylitis patient global score; BASMI: Bath ankylosing
spondylitis metrology index; BMD: Bone mineral density; BMI: Body mass
index; BV/TV: Trabecular bone volume fraction; Cort: Cortical;
CortCSA: Cortical cross-sectional area peripheral bone; CortPm: Cortical
periosteal circumference peripheral bone; CortTh: Cortical thickness
peripheral bone; CRP: C-reactive protein; CtPo: Cortical porosity;
CtPoDiam: Mean cortical pore diameter; CV: Coefficient of variation;
DCort: Volumetric BMD of cortical peripheral bone; DMARD: Disease-modifying
antirheumatic drug; DTrab: Volumetric BMD of trabecular peripheral bone;
DXA: Dual-energy x-ray absorptiometry; ESR: Erythrocyte sedimentation rate;
HRpQCT: High-resolution peripheral quantitative computed tomography;
mSASSS: Modified stoke ankylosing spondylitis spine score; NSAID: Nonsteroidal
antiinflammatory drug; QCT: Quantitative computed tomography;
TbN: Trabecular number peripheral bone; TbSp: Trabecular separation
peripheral bone; Tbth: Trabecular thickness peripheral bone; TNF: Tumor
necrosis factor; Totarea: Total bone area peripheral bone; Trab: Trabecular;
vBMD: Volumetric bone mineral density; VOI: Volume of interest.Competing interests
The authors declare that they have no competing interests.
Klingberg et al. Arthritis Research & Therapy 2013, 15:R179 Page 10 of 11
http://arthritis-research.com/content/15/6/R179Authors’ contributions
Study design was performed by EK, HF, and HC. EK, HF, ML, DM, JG, MG, and
HC conducted the study. Data were collected by EK, HF, ML, DM, JG, MG,
CO, SK, and EA. Data analysis was performed by EK, HF, ML EA, and SK. Data
were interpreted by EK and HF. EK drafted the manuscript, and EK
revisedmanuscript content. EK, HF, ML, JG, DM, MG, CO, EA, SK, and HC. EK
and HF take responsibility for the integrity of the data analysis. All authors
read and approved the final manuscript.
Acknowledgements
We thank all the patients who participated in the study.
This study was supported by grants from The Health and Medical Care
Executive Board of the Västra Götaland, Rune and Ulla Amlövs Foundation
for Rheumatology Research, Göteborg’s Association Against Rheumatism,
The Medical Society of Göteborg, the Medical Society of Göteborg, and the
Region Västra Götaland (agreement concerning research and education of
doctors), COMBINE, the Margareta Rheuma research foundation, the Inger
Bendix foundation, the Swedish Research Council, the Swedish Foundation
for Strategic Research, European Commission, the Lundberg Foundation, the
Torsten and Ragnar Söderberg’s Foundation, Petrus and Augusta Hedlund’s
Foundation, the ALF/LUA grant from the Sahlgrenska University Hospital, the
Novo Nordisk Foundation, Gustaf V and Queen Victoria’s Masonic
Foundation, and NIH R01 AR027065, and UL1 TR000135 (Mayo Center for
Translational Science Activities).
Author details
1Department of Rheumatology and Inflammation Research, Sahlgrenska
Academy at the University of Gothenburg, Gothenburg, Sweden. 2Centre for
Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at
the University of Gothenburg, Gothenburg, Sweden. 3Department of
Radiology, Sahlgrenska Hospital/Mölndal, Sahlgrenska Academy at the
University Hospital/Mölndal, Gothenburg, Sweden. 4Centre for Medical
Imaging and Physiology, Skåne University Hospital, Lund, Lund University,
Lund, Sweden. 5College of Medicine, Mayo Clinic, Rochester, MN, USA.
6College of Physiology and Medicine, Mayo Clinic, Rochester, MN, USA.
Received: 3 July 2013 Accepted: 15 October 2013
Published: 5 November 2013
References
1. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon WM, Melton LJ 3rd:
Fracture risk in patients with ankylosing spondylitis: a population based
study. J Rheum 1994, 21:1877–1882.
2. Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD: Bone
mineral density and vertebral compression fracture rates in ankylosing
spondylitis. Ann Rheum Dis 1994, 53:117–121.
3. Mitra D, Elvins DM, Speden DJ, Collins AJ: The prevalence of vertebral
fractures in mild ankylosing spondylitis and their relationship to bone
mineral density. Rheumatology (Oxford) 2000, 39:85–89.
4. Vosse D, Landewe R, van der Heijde D, van der Linden S, van Staa TP,
Geusens P: Ankylosing spondylitis and the risk of fracture: results from a
large primary care-based nested case–control study. Ann Rheum Dis 2009,
68:1839–1842.
5. Weiss RJ, Wick MC, Ackermann PW, Montgomery SM: Increased fracture
risk in patients with rheumatic disorders and other inflammatory
diseases: a case–control study with 53,108 patients with fracture.
J Rheum [Research Support, Non-U.S. Gov’t] 2010, 37:2247–2250.
6. Robinson Y, Sanden B, Olerud C: Increased occurrence of spinal fractures
related to ankylosing spondylitis: a prospective 22-year cohort study in
17,764 patients from a national registry in Sweden. Patient Saf Surg 2013, 7:2.
7. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J: Bone loss is detected
more frequently in patients with ankylosing spondylitis with
syndesmophytes. J Rheum 2005, 32:1290–1298.
8. van der Weijden MA, van Denderen JC, Lems WF, Heymans MW, Dijkmans BA,
van der Horst-Bruinsma IE: Low bone mineral density is related to male
gender and decreased functional capacity in early spondylarthropathies.
Clin Rheumatol 2011, 30:497–503.
9. Gratacos J, Collado A, Pons F, Osaba M, Sanmarti R, Roque M, Larrosa M,
Munoz-Gomez J: Significant loss of bone mass in patients with early,
active ankylosing spondylitis: a followup study. Arthritis Rheum 1999,
42:2319–2324.10. Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C: Changes in
bone density in patients with ankylosing spondylitis: a two-year
follow-up study. Osteoporos Int 2001, 12:605–609.
11. Jun JB, Joo KB, Her MY, Kim TH, Bae SC, Yoo DH, Kim SK: Femoral bone
mineral density is associated with vertebral fractures in patients with
ankylosing spondylitis: a cross-sectional study. J Rheum 2006,
33:1637–1641.
12. Ralston SH, Urquhart GD, Brzeski M, Sturrock RD: Prevalence of vertebral
compression fractures due to osteoporosis in ankylosing spondylitis.
BMJ 1990, 300:563–565.
13. Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E,
Hedberg M, Carlsten H, Forsblad-d’Elia H: Osteoporosis in ankylosing
spondylitis: prevalence, risk factors and methods of assessment.
Arthritis Res Ther [Research Support, Non-U.S. Gov’t] 2012, 14:R108.
14. El Maghraoui A: Osteoporosis and ankylosing spondylitis. Joint Bone Spine
2004, 71:291–295.
15. Lange U, Kluge A, Strunk J, Teichmann J, Bachmann G: Ankylosing
spondylitis and bone mineral density: what is the ideal tool for
measurement? Rheum Int 2005, 26:115–120.
16. Szulc P, Munoz F, Duboeuf F, Marchand F, Delmas PD: Bone mineral
density predicts osteoporotic fractures in elderly men: the MINOS study.
Osteoporos Int 2005, 16:1184–1192.
17. Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E,
Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA: Fracture incidence
and association with bone mineral density in elderly men and women:
the Rotterdam Study. Bone 2004, 34:195–202.
18. Fields AJ, Eswaran SK, Jekir MG, Keaveny TM: Role of trabecular
microarchitecture in whole-vertebral body biomechanical behavior.
J Bone Miner Res 2009, 24:1523–1530.
19. Seeman E: The growth and age-related origins of bone fragility in men.
Calcif Tissue Int 2004, 75:100–109.
20. Fields AJ, Nawathe S, Eswaran SK, Jekir MG, Adams MF, Papadopoulos P,
Keaveny TM: Vertebral fragility and structural redundancy. J Bone Miner
Res 2012, 27:2152–2158.
21. van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria
for ankylosing spondylitis: a proposal for modification of the New York
criteria. Arthritis Rheum 1984, 27:361–368.
22. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S: Age- and
gender-related differences in the geometric properties and biomechanical
significance of intracortical porosity in the distal radius and tibia.
J Bone Miner Res [Research Support, N.I.H., Extramural] 2010, 5:983–993.
23. Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK:
Postmenopausal women with osteopenia have higher cortical porosity
and thinner cortices at the distal radius and tibia than women with
normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res [Comparative
Study Research Support, Non-U.S. Gov’t Validation Studies] 2010,
25:882–890.
24. Laib A, Hauselmann HJ, Ruegsegger P: In vivo high resolution 3D-QCT of
the human forearm. Technol Health Care 1998, 6:329–337.
25. Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK: Reproducibility of
direct quantitative measures of cortical bone microarchitecture of the
distal radius and tibia by HR-pQCT. Bone [Research Support, N.I.H.,
Extramural Research Support, Non-U.S. Gov’t] 2010, 47:519–528.
26. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R:
Guidelines for assessment of bone microstructure in rodents using
micro-computed tomography. J Bone Miner Res [Review] 2010,
25:1468–1486.
27. Genant HK, Wu CY, van Kuijk C, Nevitt MC: Vertebral fracture assessment
using a semiquantitative technique. J Bone Miner Res 1993, 8:1137–1148.
28. Creemers MC, Franssen MJ, van’t Hof MA, Gribnau FW, van de Putte LB,
van Riel PL: Assessment of outcome in ankylosing spondylitis: an
extended radiographic scoring system. Ann Rheum Dis 2005, 64:127–129.
29. Sarikaya S, Basaran A, Tekin Y, Ozdolap S, Ortancil O: Is osteoporosis
generalized or localized to central skeleton in ankylosing spondylitis?
J Clin Rheumatol 2007, 13:20–24.
30. Toussirot E, Michel F, Wendling D: Bone density, ultrasound
measurements and body composition in early ankylosing spondylitis.
Rheumatology (Oxford) 2001, 40:882–888.
31. Lee YS, Schlotzhauer T, Ott SM, van Vollenhoven RF, Hunter J, Shapiro J,
Marcus R, McGuire JL: Skeletal status of men with early and late
ankylosing spondylitis. Am J Med 1997, 103:2333–2341.
Klingberg et al. Arthritis Research & Therapy 2013, 15:R179 Page 11 of 11
http://arthritis-research.com/content/15/6/R17932. Amin S, Khosla S: Sex- and age-related differences in bone microarchitecture
in men relative to women assessed by high-resolution peripheral
quantitative computed tomography. J Osteoporos 2012, 2012:129760.
33. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M, Peterson
JM, Melton LJ: Effects of sex and age on bone microstructure at the
ultradistal radius: a population-based noninvasive in vivo assessment.
J Bone Miner Res [Comparative Study Research Support, N.I.H., Extramural]
2006, 21:124–131.
34. Szulc P, Boutroy S, Vilayphiou N, Chaitou A, Delmas PD, Chapurlat R:
Cross-sectional analysis of the association between fragility fractures and
bone microarchitecture in older men: the STRAMBO study. J Bone Miner
Res 2011, 26:1358–1367.
35. Boutroy S, Bouxsein ML, Munoz F, Delmas PD: In vivo assessment of
trabecular bone microarchitecture by high-resolution peripheral
quantitative computed tomography. J Clin Endocrinol Metab 2005,
90:6508–6515.
36. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD: Alterations of cortical
and trabecular architecture are associated with fractures in
postmenopausal women, partially independent of decreased BMD
measured by DXA: the OFELY study. J Bone Miner Res 2007, 22:425–433.
37. Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL: Association
of 1.25 vitamin D3 deficiency, disease activity and low bone mass in
ankylosing spondylitis. Osteoporos Int 2005, 16:1999–2004.
doi:10.1186/ar4368
Cite this article as: Klingberg et al.: Bone microarchitecture in ankylosing
spondylitis and the association with bone mineral density, fractures,
and syndesmophytes. Arthritis Research & Therapy 2013 15:R179.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
